Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TACI Protein (AA 2-118) (Fc Tag)

TNFRSF13B Origin: Human, Mouse Host: HEK-293 Cells Recombinant >90 % (SDS-PAGE) SDS Active
Catalog No. ABIN1344232
  • Target See all TACI (TNFRSF13B) Proteins
    TACI (TNFRSF13B) (Tumor Necrosis Factor Receptor Superfamily, Member 13B (TNFRSF13B))
    Protein Type
    Recombinant
    Biological Activity
    Active
    Protein Characteristics
    AA 2-118
    Origin
    Human, Mouse
    Source
    • 6
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    HEK-293 Cells
    Purification tag / Conjugate
    This TACI protein is labelled with Fc Tag.
    Application
    SDS-PAGE (SDS)
    Purpose
    TACI (human):Fc (human) (rec.)
    Specificity
    Binds to human and mouse BAFF and APRIL.
    Cross-Reactivity
    Human, Mouse
    Characteristics
    The extracellular domain of human TACI (aa 2-118) is fused at the C-terminus to the Fc portion of human IgG1.
    Purity
    >90 % (SDS-PAGE)
    Endotoxin Level
    <0.01EU/μg purified protein (LAL test).
    Biological Activity Comment
    Inhibits BAFF and APRIL activity.
    Top Product
    Discover our top product TNFRSF13B Protein
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute with 50 μL sterile water.
    Concentration
    1 mg/mL
    Buffer
    Contains PBS.
    Handling Advice
    After reconstitution, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1 % BSA should be used for further dilutions.
    Storage
    4 °C,-20 °C
    Storage Comment

    Short Term Storage: +4°C

    Long Term Storage: -20°C

    Use & Stability: Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

    Expiry Date
    6 months
  • Huard, Tran, Benkhoucha, Manzin-Lorenzi, Santiago-Raber: "Selective APRIL blockade delays systemic lupus erythematosus in mouse." in: PLoS ONE, Vol. 7, Issue 2, pp. e31837, (2012) (PubMed).

  • Target
    TACI (TNFRSF13B) (Tumor Necrosis Factor Receptor Superfamily, Member 13B (TNFRSF13B))
    Alternative Name
    TACI (TNFRSF13B Products)
    Background

    TNFRSF 13B, Tumor Necrosis Factor Receptor Superfamily Member 13B, Transmembrane Activator and CAML interactor, CD267

    B-cell activating factor belonging to the TNF family receptor (BAFF-R), B-cell maturation antigen (BCMA), and transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) play critical functions in promoting B-cell survival by engaging the ligands a proliferation-inducing ligand (APRIL) and/or BAFF. TACI is predominantly expressed on peripheral blood B cells and interacts with the B cell activating factor (BAFF) of ligands and a proliferation inducing ligand (APRIL), which are expressed by numerous cell types, including dendritic cells, macrophages and neutrophils. TNFRSF13B, the gene, which encodes TACI is mutated in nearly 10 % of patients with common variable immune deficiency (CVID), an antibody deficiency syndrome characterized by loss of memory B cells and plasma cells.

    Molecular Weight
    ~45kDa (SDS-PAGE)
    UniProt
    O14836
You are here:
Support